Kaynak: MarketBeat
Haber Ajansı
Hisse Senedi
Orta Önem
Stevanato Group Q2 Earnings Call Highlights
Stevanato Group NYSE: STVN reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its full-year outlook to reflect the divestiture of its California-based Balda C. Brewer subsidiary.
İlgili Semboller
1
S
STVN
STVN
Kaynak: MarketBeat
Kaynağı Ziyaret Et